180 related articles for article (PubMed ID: 25629396)
21. Organism-adapted specificity of the allosteric regulation of pyruvate kinase in lactic acid bacteria.
Veith N; Feldman-Salit A; Cojocaru V; Henrich S; Kummer U; Wade RC
PLoS Comput Biol; 2013; 9(7):e1003159. PubMed ID: 23946717
[TBL] [Abstract][Full Text] [Related]
22. Fructose-1,6-bisphosphate-activated pyruvate kinase from Escherichia coli. Nature of bonds involved in the allosteric mechanism.
Speranza ML; Valentini G; Malcovati M
Eur J Biochem; 1990 Aug; 191(3):701-4. PubMed ID: 2202599
[TBL] [Abstract][Full Text] [Related]
23. The contribution of two isozymes to the pyruvate kinase activity of Vibrio cholerae: One K+-dependent constitutively active and another K+-independent with essential allosteric activation.
Guerrero-Mendiola C; García-Trejo JJ; Encalada R; Saavedra E; Ramírez-Silva L
PLoS One; 2017; 12(7):e0178673. PubMed ID: 28686591
[TBL] [Abstract][Full Text] [Related]
24. Benchmarking predictions of allostery in liver pyruvate kinase in CAGI4.
Xu Q; Tang Q; Katsonis P; Lichtarge O; Jones D; Bovo S; Babbi G; Martelli PL; Casadio R; Lee GR; Seok C; Fenton AW; Dunbrack RL
Hum Mutat; 2017 Sep; 38(9):1123-1131. PubMed ID: 28370845
[TBL] [Abstract][Full Text] [Related]
25. An absolute requirement of fructose 1,6-bisphosphate for the Lactobacillus casei L-lactate dehydrogenase activity induced by a single amino acid substitution.
Arai K; Hishida A; Ishiyama M; Kamata T; Uchikoba H; Fushinobu S; Matsuzawa H; Taguchi H
Protein Eng; 2002 Jan; 15(1):35-41. PubMed ID: 11842236
[TBL] [Abstract][Full Text] [Related]
26. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis.
Dombrauckas JD; Santarsiero BD; Mesecar AD
Biochemistry; 2005 Jul; 44(27):9417-29. PubMed ID: 15996096
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of the neutral form of fructose 1,6-bisphosphatase complexed with regulatory inhibitor fructose 2,6-bisphosphate at 2.6-A resolution.
Liang JY; Huang S; Zhang Y; Ke H; Lipscomb WN
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2404-8. PubMed ID: 1312721
[TBL] [Abstract][Full Text] [Related]
28. The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate.
Jurica MS; Mesecar A; Heath PJ; Shi W; Nowak T; Stoddard BL
Structure; 1998 Feb; 6(2):195-210. PubMed ID: 9519410
[TBL] [Abstract][Full Text] [Related]
29. Determinants of allosteric activation of yeast pyruvate kinase and identification of novel effectors using computational screening.
Bond CJ; Jurica MS; Mesecar A; Stoddard BL
Biochemistry; 2000 Dec; 39(50):15333-43. PubMed ID: 11112519
[TBL] [Abstract][Full Text] [Related]
30. Kinetic and allosteric consequences of mutations in the subunit and domain interfaces and the allosteric site of yeast pyruvate kinase.
Fenton AW; Blair JB
Arch Biochem Biophys; 2002 Jan; 397(1):28-39. PubMed ID: 11747307
[TBL] [Abstract][Full Text] [Related]
31. The allosteric effect of fructose bisphosphate on muscle pyruvate kinase studied by infrared spectroscopy.
Kumar S; Barth A
J Phys Chem B; 2011 Oct; 115(39):11501-5. PubMed ID: 21870844
[TBL] [Abstract][Full Text] [Related]
32. The putative effector-binding site of Leishmania mexicana pyruvate kinase studied by site-directed mutagenesis.
Hannaert V; Yernaux C; Rigden DJ; Fothergill-Gilmore LA; Opperdoes FR; Michels PA
FEBS Lett; 2002 Mar; 514(2-3):255-9. PubMed ID: 11943161
[TBL] [Abstract][Full Text] [Related]
33. Interaction of non-phosphorylated liver pyruvate kinase with fructose 1,6-bisphosphate and peptides that mimic the phosphorylatable N-terminus of the enzyme.
Faustova I; Järv J
Protein Pept Lett; 2013 Nov; 20(11):1200-3. PubMed ID: 23713905
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of a complex of Escherichia coli glycerol kinase and an allosteric effector fructose 1,6-bisphosphate.
Ormö M; Bystrom CE; Remington SJ
Biochemistry; 1998 Nov; 37(47):16565-72. PubMed ID: 9843423
[TBL] [Abstract][Full Text] [Related]
35. Identification of substrate contact residues important for the allosteric regulation of phosphofructokinase from Eschericia coli.
Fenton AW; Paricharttanakul NM; Reinhart GD
Biochemistry; 2003 Jun; 42(21):6453-9. PubMed ID: 12767227
[TBL] [Abstract][Full Text] [Related]
36. Mutational mimics of allosteric effectors: a genome editing design to validate allosteric drug targets.
Tang Q; Villar MT; Artigues A; Thyfault JP; Apte U; Zhu H; Peterson KR; Fenton AW
Sci Rep; 2019 Jun; 9(1):9031. PubMed ID: 31227746
[TBL] [Abstract][Full Text] [Related]
37. Structural and functional linkages between subunit interfaces in mammalian pyruvate kinase.
Wooll JO; Friesen RH; White MA; Watowich SJ; Fox RO; Lee JC; Czerwinski EW
J Mol Biol; 2001 Sep; 312(3):525-40. PubMed ID: 11563914
[TBL] [Abstract][Full Text] [Related]
38. Native Mass Spectrometry Gives Insight into the Allosteric Binding Mechanism of M2 Pyruvate Kinase to Fructose-1,6-Bisphosphate.
Gavriilidou AFM; Holding FP; Mayer D; Coyle JE; Veprintsev DB; Zenobi R
Biochemistry; 2018 Mar; 57(11):1685-1689. PubMed ID: 29499117
[TBL] [Abstract][Full Text] [Related]
39. Synergistic Allosteric Mechanism of Fructose-1,6-bisphosphate and Serine for Pyruvate Kinase M2 via Dynamics Fluctuation Network Analysis.
Yang J; Liu H; Liu X; Gu C; Luo R; Chen HF
J Chem Inf Model; 2016 Jun; 56(6):1184-1192. PubMed ID: 27227511
[TBL] [Abstract][Full Text] [Related]
40. Modulation of the phosphorylation state of rat liver pyruvate kinase by allosteric effectors and insulin.
Claus TH; El-Maghrabi MR; Pilkis SJ
J Biol Chem; 1979 Aug; 254(16):7855-64. PubMed ID: 468793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
